Research and Markets: Lung Infections Pipeline Insights 2015 - Reviews Key Players Involved in the Therapeutics Development for Lung Infections

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/cqmdvq/lung) has announced the addition of the "Lung Infections-Pipeline Insights" report to their offering.

Summary

Lung Infections- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Lung Infections. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Lung Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Lung Infections- Pipeline Insights Report covers the Lung Infections pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Lung Infections related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Lung Infections.

Scope

  • The report provides a Lung Infections Landscape across the globe
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
  • Coverage of the Lung Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • Pipeline products coverage based on various stages of development from NDA filings to discovery.

Key Topics Covered:

  • Lung Infections Overview
  • Lung Infections Pipeline Therapeutics
  • Lung Infections Therapeutics under Development by Companies
  • Lung Infections Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Lung Infections Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Lung Infections Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Lung Infections Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Lung Infections - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Lung Infections - Discontinued Products
  • Lung Infections - Dormant Products
  • Companies Involved in Therapeutics Development for Lung Infections

For more information visit http://www.researchandmarkets.com/research/cqmdvq/lung

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals